Cargando…
Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression
Breast cancer causes the No.1 women cancer prevalence and the No.2 women cancer mortality worldwide. Nuclear receptor/transcriptional factor signaling is aberrant and plays important roles in breast cancer pathogenesis and evolution, such as estrogen receptor α (ERα/ESR1), tumor protein p53 (p53/TP5...
Autores principales: | Zhu, Jian, Zhuang, Ting, Yang, Huijie, Li, Xin, Liu, Huandi, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962416/ https://www.ncbi.nlm.nih.gov/pubmed/27460922 http://dx.doi.org/10.1186/s12885-016-2575-8 |
Ejemplares similares
-
The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression
por: Yuan, Lei, et al.
Publicado: (2022) -
The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
por: Zhu, J, et al.
Publicado: (2014) -
Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
por: Zhu, J., et al.
Publicado: (2018) -
The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression
por: Zhu, Jian, et al.
Publicado: (2020) -
Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187
por: Li, Xin, et al.
Publicado: (2022)